USD $5.00-7.00 / Gram
USD $1.00-1.00 / Gram
USD $1.00-1.00 / Gram
USD $1.00-1.00 / Gram
USD $1.00-1.00 / Gram
USD $1.00-1.00 / Gram
USD $1.00-1.00 / Gram
USD $8.80-8.80 / Gram
USD $8.80-8.80 / Gram
product name: | bosutinib |
synonyms: | ski-606;bosutinib;bosutinib for research;4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile;bosutinib ( ski-606 );3-quinolinecarbonitrile, 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-;bosutinib(tinibs );4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile bosutinib (ski-606) |
cas: | 380843-75-4 |
mf: | c26h29cl2n5o3 |
mw: | 530.45 |
einecs: | |
product categories: | api;aromatics compounds;aromatics;heterocycles;inhibitors;intermediates & fine chemicals;pfizer compounds;pharmaceuticals |
bosutinib chemical properties |
mp | 116-120 ºc |
density | 1.36 |
storage temp. | room temp |
cas database reference | 380843-75-4(cas database reference) |
bosutinib usage and synthesis |
chemical properties | pale yellow solid |
usage | a novel src kinase inhibitor, suppresses migration and invasion of human breast cancer cells. |
usage | peripheral vasolidator increases cerebral blood flow, potential therapeutic for altzheimer’s disease, cognitive impairment and dementia |
usage | bosutinib (ski-606) is a novel, dual src/abl inhibitor with ic50 of 1.2 nm and 1 nm, |